BDD Evaluation & Medication Management

Body Dysmorphic Disorder Evaluation & Medication Management

Dr. Monika Thangada, MD provides specialized psychiatric evaluation and medication management for body dysmorphic disorder. As a board-certified MD psychiatrist with expertise in OCD-spectrum conditions, she conducts thorough assessments to confirm BDD diagnosis, evaluate severity, and develop evidence-based medication and treatment plans.

Why Specialized Psychiatric Evaluation Matters for BDD

BDD is often misunderstood or missed entirely. Many individuals suffer for years without accurate diagnosis. A specialized psychiatric evaluation is essential to:

• Confirm diagnosis: BDD vs. other conditions that may appear similar
• Assess severity: Mild, moderate, or severe; implications for treatment intensity
• Identify comorbidities: Depression, anxiety, OCD, eating disorder that require integrated treatment
• Establish medical safety: Labs, cardiac monitoring, baseline health assessment
• Evaluate suicide risk: BDD is associated with elevated suicide risk; careful assessment is crucial
• Guide medication selection: Determining which SSRI and dosing are appropriate
• Develop treatment plan: Coordinating with therapists and other providers

Initial Psychiatric Evaluation

Duration: 60-90 minutes

Comprehensive assessment includes:

Part 1: Detailed Appearance Preoccupation History

What body areas are you preoccupied with?

• Facial features (nose, skin, eyes, mouth, chin, cheeks)
• Hair (thickness, color, distribution)
• Body shape or muscularity
• Genitals
• Breasts or chest
• Legs or arms
• Hands or feet
• Specific asymmetries

How do you perceive these areas?

• What's the "flaw"? Describe it in detail
• How noticeable is it to others? (Important: BDD often involves minor or unnoticeable flaws)
• How much does it bother you? (On scale of 0-100)
• How many hours per day do you think about it?
• Are thoughts intrusive (unwanted, hard to dismiss)? Or can you push them away?

How did the preoccupation start?

• When did it begin?
• What triggered it? (Comment from someone? Social media? Comparing to others?)
• Has it worsened or improved over time?
• Have you been able to stop focusing on it?

What behaviors or mental acts do you do in response?

Compulsive behaviors:

• Mirror checking: How often? For how long? Does it help or hurt?
• Mirror avoidance: Do you avoid mirrors entirely?
• Grooming: How much time on grooming? Is it excessive? Does it cause physical harm?
• Reassurance-seeking: Do you ask others "Do I look okay?" repeatedly? Does reassurance help?
• Body checking: Measuring, photographing, examining the area repeatedly?
• Camouflaging: What do you wear/do to hide the area? How much does this restrict your life?
• Excessive exercise (especially if muscle-focused preoccupation)
• Cosmetic procedures: Any surgeries or procedures? How many? Did they help?

Mental acts:

• Rumination: Thinking repeatedly about the flaw?
• Mental comparison: Comparing yourself to others constantly?
• Mental checking: Reviewing the appearance in your mind?

Impact on functioning:

• Social: Do you avoid social situations? Dating? Going out in public?
• Occupational/Academic: Does preoccupation interfere with concentration? Missed work/school?
• Relationships: Impact on relationships? Do loved ones express concern?
• Daily activities: Any activities you avoid or limit?
• Quality of life: Overall impact on happiness and functioning?

Part 2: Psychiatric History

Current mood and anxiety:

• Depression symptoms: Mood, sleep, energy, motivation, suicidal thoughts
• Anxiety: General anxiety, social anxiety, panic, worry
• OCD symptoms: Obsessions, compulsions beyond appearance (checking, counting, contamination fears, etc.)
• ADHD symptoms: Inattention, hyperactivity, impulsivity
• Trauma: Any significant traumatic experiences?

Previous psychiatric treatment:

• Therapy: What kind? Outcome?
• Medications tried: Which ones? Doses? How long on each? Side effects? Why discontinued?
• Diagnoses given: Any previous BDD, OCD, anxiety, depression diagnoses?

Family psychiatric history:

• BDD, OCD, or body image issues in family?
• Depression, anxiety, or other psychiatric conditions?
• Suicides in family?

Part 3: Medical and Medication History

Current medications:

• List all prescription and over-the-counter medications
• Supplements or herbs
• Any drug or alcohol use

Medical conditions:

• Any significant medical illnesses?
• Previous surgeries or hospitalizations?
• Chronic pain or other ongoing medical issues?

Medication tolerances/allergies:

• Any adverse reactions to medications?
• Which medications have worked well? Poorly?

For females:

• Pregnancy/lactation status
• Contraceptive use
• Menstrual history

Physical symptoms related to preoccupation:

• Any self-injury related to checking or grooming?
• Sleep disruption due to preoccupation?
• Nutritional status if muscle dysmorphia present

Part 4: Physical Examination

• Vital signs: Blood pressure, heart rate, respiratory rate, temperature
• General appearance: Noting overall presentation (what might the person be focusing on?)
• Skin: Assessment for self-injury or excessive grooming effects
• Neurological screening: Basic mental status, orientation, cognition
• Cardiovascular assessment: Listening for heart rhythm

Part 5: Mental Status Examination

• Appearance and behavior: Overall presentation, grooming, posture
• Mood and affect: Current mood, range of emotions
• Speech: Rate, volume, coherence
• Thought process: Organization, clarity
• Thought content: Obsessions, preoccupations, suicidal/homicidal ideation
• Cognition: Orientation, memory, concentration
• Insight: Awareness of problem, willingness to get treatment
• Judgment: Decision-making capacity
• Risk assessment: Suicide, self-harm

Part 6: Baseline Labora Screening

Labs typically ordered:

1. Complete Metabolic Panel

• Electrolytes (sodium, potassium, chloride)
• Glucose (fasting if possible)
• Liver function: AST, ALT
• Kidney function: Creatinine, BUN
• Why: Baseline health; SSRIs can affect sodium in rare cases

1. Complete Blood Count

• Hemoglobin, hematocrit, white blood cells, platelets
• Why: Screen for anemia; baseline hematologic function

1. Thyroid Function

• TSH, Free T4
• Why: Thyroid dysfunction can mimic or worsen anxiety; important baseline

1. Prolactin (if indicated)

• Why: Some medications can affect prolactin; baseline important

EKG (Electrocardiogram):

• Often obtained at baseline for older individuals or if cardiac symptoms
• Helps establish baseline rhythm and structural info

Urine drug screen: If substance use history or concerns

Assessment of Suicide Risk

BDD is associated with significantly elevated suicide risk (30-40% lifetime suicidal ideation; 5-10% attempt). Suicide risk assessment is critical.

Questions asked:

• Have you had thoughts of wanting to hurt yourself or die?
• How often? How intense? How much do you think about it?
• Do you have a plan? A method? Means available?
• Have you ever attempted?
• What keeps you alive? What gives you hope?
• Current protective factors?

Risk factors in BDD:

• Functional impairment and isolation
• Comorbid depression
• Poor treatment response
• Substance use
• Male gender (higher completion rates)
• Access to means

If suicide risk identified:

• Develop safety plan
• More frequent monitoring
• Consider higher level of care if acute risk
• Coordinate with therapist
• May need crisis resources

Medication Management for Body Dysmorphic Disorder

Why SSRIs for BDD?

SSRIs work in BDD because:

• BDD involves serotonergic dysfunction in brain regions governing obsessive thoughts, anxiety, and perfectionism
• SSRIs increase serotonin availability in these regions
• Higher doses needed for BDD (similar to OCD) compared to depression
• Response rates: 60-70% with adequate dosing and duration

First-Line SSRIs

1. Fluoxetine (Prozac)

Dosing for BDD:

• Start: 20 mg/day
• Target: 60 mg/day
• Maximum: 80 mg/day
• Important: Doses of 20-40 mg (typical for depression) are often insufficient for BDD; therapeutic dose is 60+ mg

Dosing schedule:

• Week 1: 20 mg daily (morning preferred)
• Week 2-3: 40 mg daily (if tolerated)
• Week 4+: 60 mg daily (therapeutic dose)
• Weeks 8-12: Assess response at therapeutic dose

Response:

• Early response (weeks 2-4): Reduced side effects, slightly improved anxiety
• Therapeutic response (weeks 8-12): Significant reduction in preoccupation, compulsions, distress
• Full response: Weeks 12+ for maximum benefit

Half-life: Long (1-3 days); flexibility if dose missed

Accumulation: Reaches steady state in 4-5 weeks at new dose; wait this long before assessing response

Side effects:

• Nausea (40-50% initially): Usually transient; take with food, ginger, anti-nausea med if severe
• Insomnia (15-20%): Take in morning; sleep hygiene; temporary sleep aid
• Activation/jitteriness (10-15%): Usually resolves; dose adjustment if severe
• Headache (15-20%): Usually self-limited
• Sexual side effects (10-15%): Dose-related; may improve over time; alternatives available
• Weight changes: Usually minimal with fluoxetine

Advantages:

• Most research in BDD specifically
• Clear dosing guidelines
• Once-daily dosing
• Long half-life provides flexibility

Disadvantages:

• Can cause activation
• Sexual effects common at higher doses
• Longer taper needed if discontinuing

2. Fluvoxamine (Luvox)

Dosing for BDD:

• Start: 50 mg at bedtime
• Target: 100-300 mg/day (divided, usually 2x daily)
• Maximum: 300 mg/day

Advantages:

• FDA-approved for OCD (strong evidence base)
• Effective for OCD-like features in BDD
• Less activation than fluoxetine
• Less sexual effects than fluoxetine

Disadvantages:

• Twice-daily dosing (less convenient)
• More drug interactions than fluoxetine
• Short half-life (requires more consistent timing)
• More expensive for brand name

Half-life: Short (8-15 hours); twice-daily dosing needed

3. Sertraline (Zoloft)

Dosing for BDD:

• Start: 50 mg/day
• Target: 100-200 mg/day
• Maximum: 200 mg/day

Advantages:

• Good tolerability
• Once-daily dosing
• Fewer drug interactions
• Moderate cost

Disadvantages:

• Less extensive research in BDD compared to fluoxetine
• May be less effective in OCD-like features

4. Paroxetine (Paxil)

Dosing for BDD:

• Target: 40-80 mg/day

Advantages:

• Strong anti-anxiety effect
• Once-daily dosing

Disadvantages:

• Weight gain more common
• Sexual dysfunction common
• Significant withdrawal symptoms
• Less preferred for long-term use

Dosing Philosophy for BDD

KEY PRINCIPLE: ADEQUATE DOSE FOR ADEQUATE TIME

• Adequate dose: At least 60 mg fluoxetine (or equivalent); half-doses are often insufficient for BDD
• Adequate time: Minimum 8 weeks at therapeutic dose before assessing response; 12 weeks often needed
• Premature discontinuation: Many treatment "failures" result from inadequate dose or too-brief trial

Response assessment timeline:

• Weeks 1-2: Side effect tolerance
• Weeks 2-4: Early response signs (reduced anxiety, better sleep)
• Weeks 4-8: Gradual improvement in preoccupation and compulsions
• Weeks 8-12: Therapeutic response assessment; if inadequate response, consider dose increase or switch
• Week 12+: Full response typically achieved by this point

What to Expect During Treatment

First 1-2 weeks:

• Possible side effects (nausea, insomnia, activation)
• No noticeable improvement yet (drug hasn't reached full effect)
• Takes 4-5 weeks to reach steady state

Weeks 2-4:

• Side effects usually lessening
• Possible slight improvement in anxiety or sleep
• Preoccupation may still be prominent

Weeks 4-8:

• More noticeable reduction in preoccupation frequency
• Compulsions may feel slightly less powerful
• Thoughts still present but less distressing
• Improving tolerance for not engaging in compulsions

Weeks 8-12:

• Significant improvement in preoccupation intensity and frequency
• Compulsions markedly reduced or manageable
• Anxiety from "resisting" compulsions diminished
• Noticeable improvement in functioning

Beyond 12 weeks:

• Continued gradual improvement
• Maximum benefit often by 4-6 months
• Brain continues adapting to medication

If First SSRI is Inadequate

If no response after 8-12 weeks at adequate dose:

1. Confirm adequate dosing: Are you really at 60+ mg fluoxetine (or equivalent)?
2. Consider higher dose: May need 70-80 mg fluoxetine; some need maximum doses
3. Try alternative SSRI: Different SSRIs have different response rates; 60% respond to fluoxetine but different 60% may respond to fluvoxamine

If partial response:

• Continue current medication; improvement may continue beyond 12 weeks
• Augmentation strategies: Adding certain medications to enhance response
• Therapy essential for partial responders

Duration of Treatment

Acute treatment phase: 8-12 weeks to assess response

Treatment continuation: 6-12 months minimum after achieving remission or good response

Long-term maintenance:

• Many individuals benefit from 1-2+ years of medication
• Some continue indefinitely if relapse risk is high
• Decision made with psychiatrist based on:
• Severity of initial illness
• Relapse risk
• Personal preference
• Response to previous discontinuation attempts

If discontinuing medication:

• Gradual taper over 4-6+ weeks
• Abrupt discontinuation risks withdrawal symptoms and relapse
• Close monitoring during taper
• Therapist involvement important
• May resume medication if relapse occurs

Psychiatric Appointments During Treatment

Initial phase (first 8-12 weeks if on medication):

• Week 1-2: Phone or brief in-person contact to assess early side effects
• Week 2-4: In-person appointment to discuss dose, side effects, early response
• Week 4-8: Every 2-4 weeks for ongoing assessment
• Week 8-12: Every 4 weeks for therapeutic response evaluation

Ongoing medication management:

• Once stabilized: Every 4-8 weeks
• Then: Monthly to quarterly appointments
• Focus: Medication efficacy, side effects, functioning, mood/safety, coordination with therapy

Labs during treatment:

• Baseline: Before starting medication
• 2-4 weeks: If early concerns
• 8 weeks: Full metabolic panel, thyroid
• Then: Every 8-12 weeks during acute phase
• Maintenance: Every 3-6 months or as clinically indicated

Coordination with Therapist

Essential coordination:

• Regular communication between psychiatrist and therapist
• Psychiatrist focuses on medication management, comorbidities, medical safety
• Therapist focuses on CBT-ERP, behavioral work, coping skills
• Shared treatment goals
• Adjustment of approaches based on progress

Frequency:

• Psychiatry: Every 2-4 weeks during acute phase, then monthly to quarterly
• Therapy: Weekly (typically)
• Communication: After psychiatry appointments; phone/email as needed

FAQs About BDD Medication and Evaluation

Q: How long until medication helps?

A: Most people notice some improvement within 2-4 weeks, but significant improvement takes 8-12 weeks at therapeutic dose. Patience is essential.

Q: Why such a high dose of fluoxetine?

A: BDD, like OCD, requires higher SSRI doses than depression. Doses of 20-40 mg (depression dosing) are often insufficient. 60 mg is the therapeutic dose for BDD.

Q: What if I can't tolerate side effects?

A: Most side effects are temporary. We can adjust dosing, timing, or switch medications. Most people find side effects manageable with time and support.

Q: Will medication alone fix my BDD?

A: Medication helps significantly (60% respond), but therapy is essential for lasting recovery. Medication + therapy = 70-90% improvement. Medication alone often relapses when stopped.

Q: Can I ever stop medication?

A: Yes, but after improvement is stable (typically 6-12 months). Gradual tapering is essential. Some people maintain medication long-term to prevent relapse.

Q: What if I'm having suicidal thoughts?

A: Tell your psychiatrist immediately. This is critical. There are emergency resources available. Don't keep this secret.

Q: How do I know if the medication is working?

A: You should notice: Less frequent appearance thoughts, easier time resisting compulsions, improved mood/functioning, reduced distress about the preoccupation.

Getting Started at KwikPsych

Initial Appointment:

• Duration: 60-90 minutes
• Cost: $299 (self-pay); covered by insurance
• Includes: Complete evaluation, physical exam, baseline labs ordered, discussion of findings and treatment options

Follow-Up Appointments:

• Duration: 15-30 minutes
• Cost: $179 (self-pay); covered by insurance
• Typically: Every 2-4 weeks during first 3 months, then monthly to quarterly

Insurance Accepted:

• Aetna, BCBS, Cigna, UnitedHealthcare
• Superior HealthPlan/Ambetter, Baylor Scott & White
• Oscar, First Health Network, Optum, Medicare

Telehealth:

• Available across Texas for follow-up appointments

Crisis Support:

• If having suicidal thoughts: Call 988 or 911 immediately
• Dr. Thangada's office can often accommodate urgent appointments

Contact KwikPsych

Phone: 737-367-1230

Address: 12335 Hymeadow Dr, Ste 450, Austin, TX 78750

Body dysmorphic disorder is treatable. With specialized psychiatric evaluation, appropriate medication at adequate doses, and coordinated therapy, most people experience significant improvement and recovery. Let us help you begin the path to freedom from appearance preoccupation.